private:aclairopharmaceuticaldevelopmentgroup-2
|
1309724
|
May 21st, 2019 12:00AM
|
Aclairo Pharmaceutical Development Group, Inc.
|
159
|
17.00
|
Open
|
Pharmaceuticals
|
May 21st, 2019 06:16PM
|
May 21st, 2019 06:16PM
|
Aclairo’s experience as FDA supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities of pharmaceutical development. The Aclairo advantage is our experience-based approach to providing strategic, scientific and regulatory services. This has proven to be our greatest asset in focusing and streamlining our clients’ development efforts, reducing both time and costs.
|
Open
|
Regulatory Services, Preclinical Project Management, Scientific Writing, Preclinical ADME, US Agent Services, IND Preparation, CTD/eCTD Maintenance, Gap Analyses
|
Open
|
1950 Old Gallows Road, Suite 300
|
Vienna
|
VA
|
US
|
22182
|
|
Aclairo Pharmaceutical Development Group
|
|
Pharmaceuticals & Biotechnology
|
private:aclairopharmaceuticaldevelopmentgroup-2
|
1309724
|
Mar 12th, 2018 12:00AM
|
Aclairo Pharmaceutical Development Group, Inc.
|
138
|
15.00
|
Open
|
Pharmaceuticals
|
Mar 12th, 2018 03:29PM
|
Mar 12th, 2018 03:29PM
|
|
Open
|
|
|
|
|
|
|
|
|
Aclairo Pharmaceutical Development Group
|
|
Pharmaceuticals & Biotechnology
|
private:aclairopharmaceuticaldevelopmentgroup-2
|
1309724
|
Nov 7th, 2017 12:00AM
|
Aclairo Pharmaceutical Development Group, Inc.
|
137
|
14.00
|
Open
|
Pharmaceuticals
|
Nov 7th, 2017 04:26PM
|
Nov 7th, 2017 04:26PM
|
Aclairo’s experience as FDA supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities of pharmaceutical development. The Aclairo advantage is our experience-based approach to providing strategic, scientific and regulatory services. This has proven to be our greatest asset in focusing and streamlining our clients’ development efforts, reducing both time and costs.
|
|
|
|
|
|
|
|
|
|
Aclairo Pharmaceutical Development Group
|
|
Pharmaceuticals & Biotechnology
|
private:aclairopharmaceuticaldevelopmentgroup-2
|
1309724
|
Nov 1st, 2017 12:00AM
|
Aclairo Pharmaceutical Development Group, Inc.
|
137
|
14.00
|
Open
|
Pharmaceuticals
|
Nov 1st, 2017 04:12AM
|
Nov 1st, 2017 04:12AM
|
Aclairo’s experience as FDA supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities of pharmaceutical development. The Aclairo advantage is our experience-based approach to providing strategic, scientific and regulatory services. This has proven to be our greatest asset in focusing and streamlining our clients’ development efforts, reducing both time and costs.
|
|
|
|
|
|
|
|
|
|
Aclairo Pharmaceutical Development Group
|
|
Pharmaceuticals & Biotechnology
|